Related references
Note: Only part of the references are listed.Clostridium difficile Ribotype Does Not Predict Severe Infection
Seth T. Walk et al.
CLINICAL INFECTIOUS DISEASES (2012)
Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials
Derrick W. Crook et al.
CLINICAL INFECTIOUS DISEASES (2012)
Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial Management
David W. Eyre et al.
CLINICAL INFECTIOUS DISEASES (2012)
Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection
M. H. Wilcox
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting
Anilrudh A. Venugopal et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2012)
Co-morbidities as predictors of mortality in Clostridium difficile infection and derivation of the ARC predictive score
M. R. Welfare et al.
JOURNAL OF HOSPITAL INFECTION (2011)
Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile
Simon D. Goldenberg et al.
JOURNAL OF INFECTION (2011)
Glucocorticoids Are Associated With Increased Risk of Short-Term Mortality in Hospitalized Patients With Clostridium difficile-Associated Disease
Rohit Das et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Long-term stability of procalcitonin in frozen samples and comparison of Kryptor® and VIDAS® automated immunoassays
Philipp Schuetz et al.
CLINICAL BIOCHEMISTRY (2010)
High prevalence of tcdC deletion-carrying Clostridium difficile and lack of association with disease severity
Brandon P. Verdoorn et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
Stuart H. Cohen et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Clostridium difficile Strain NAP-1 Is Not Associated With Severe Disease in a Nonepidemic Setting
Jeffrey Cloud et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Health Care-Associated Clostridium difficile Infection in Adults Admitted to Acute Care Hospitals in Canada: A Canadian Nosocomial Infection Surveillance Program Study
Denise Gravel et al.
CLINICAL INFECTIOUS DISEASES (2009)
Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study
D. Stolz et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Effect of Procalcitonin-Based Guidelines vs Standard Guidelines on Antibiotic Use in Lower Respiratory Tract Infections The ProHOSP Randomized Controlled Trial
Philipp Schuetz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study
S. Schroeder et al.
LANGENBECKS ARCHIVES OF SURGERY (2009)
Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial
Marcel Hochreiter et al.
CRITICAL CARE (2009)
Clinical Risk Factors for Severe Clostridium difficile-associated Disease
Timothy J. Henrich et al.
EMERGING INFECTIOUS DISEASES (2009)
Use of procalcitonin to shorten antibiotic treatment duration in septic patients - A randomized trial
Vandack Nobre et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Short- and long-term attributable costs of Clostridium difficile -: Associated disease in nonsurgical inpatients
Erik R. Dubberke et al.
CLINICAL INFECTIOUS DISEASES (2008)
Measuring the severity of Clostridium difficile infection: implications for management and drug development
Jaime Belmares et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2008)
Clinical Severity of Clostridium difficile PCR Ribotype 027: A Case-Case Study
Oliver W. Morgan et al.
PLOS ONE (2008)
Bench-to-bedside review: Clostridium difficile colitis
Carolyn V. Gould et al.
CRITICAL CARE (2008)
Clostridium difficile surveillance trends, Saxony, Germany
Florian Burckhardt et al.
EMERGING INFECTIOUS DISEASES (2008)
Recommendations for surveillance of Clostridium difficile-associated disease
L. Clifford McDonald et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2007)
Severity of clostridium difficile associated disease (CDAD) in allogeneic stem cell transplant recipients: Evaluation of a CDAD severity grading system
Erik R. Dubberke et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2007)
Emergence of Clostridium difficile-associated disease in North America and Europe
E. J. Kuijper et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates
T Åkerlund et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis
Eric A. J. Hoste et al.
CRITICAL CARE (2006)
An epidemic, toxin gene-variant strain of Clostridium difficile
LC McDonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe
M Warny et al.
LANCET (2005)
Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitis
KR Herrlinger et al.
INFLAMMATORY BOWEL DISEASES (2004)
Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea
L Kyne et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2002)
Antibiotic-associated diarrhea
JG Bartlett
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
